Renaissance Technologies’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $758K | Sell |
468,112
-233,319
| -33% | -$378K | ﹤0.01% | 2636 |
|
|
2025
Q1 | $503K | Buy |
701,431
+171,931
| +32% | +$123K | ﹤0.01% | 2740 |
|
|
2024
Q4 | $588K | Sell |
529,500
-226,511
| -30% | -$251K | ﹤0.01% | 2770 |
|
|
2024
Q3 | $529K | Buy |
756,011
+260,711
| +53% | +$182K | ﹤0.01% | 2767 |
|
|
2024
Q2 | $495K | Buy |
495,300
+160,642
| +48% | +$161K | ﹤0.01% | 2694 |
|
|
2024
Q1 | $793K | Buy |
334,658
+283,058
| +549% | +$671K | ﹤0.01% | 2631 |
|
|
2023
Q4 | $116K | Buy |
51,600
+15,100
| +41% | +$33.9K | ﹤0.01% | 3266 |
|
|
2023
Q3 | $77K | Buy |
36,500
+100
| +0.3% | +$211 | ﹤0.01% | 3300 |
|
|
2023
Q2 | $112K | Buy |
36,400
+8,000
| +28% | +$24.6K | ﹤0.01% | 3444 |
|
|
2023
Q1 | $153K | Sell |
28,400
-17,567
| -38% | -$94.6K | ﹤0.01% | 3366 |
|
|
2022
Q4 | $306K | Buy |
45,967
+14,067
| +44% | +$93.6K | ﹤0.01% | 3210 |
|
|
2022
Q3 | $127K | Buy |
31,900
+14,600
| +84% | +$58.1K | ﹤0.01% | 3517 |
|
|
2022
Q2 | $86K | Buy |
+17,300
| New | +$86K | ﹤0.01% | 3886 |
|